Teva’s Legal Woes Lead To $4.6bn Hit
‘Frustrating’ Legal Situation On Price-Fixing Could Last For Years
Teva reported a substantial loss in the third quarter after registering a goodwill impairment of $4.6bn, largely linked to legal uncertainties as the firm continues to grapple with price-fixing litigation in the US and its pending opioids settlement.
